BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27578133)

  • 1. Statin treatment is associated with insulin sensitivity decrease in type 1 diabetes mellitus: A prospective, observational 56-month follow-up study.
    Duvnjak L; Blaslov K
    J Clin Lipidol; 2016; 10(4):1004-1010. PubMed ID: 27578133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes Secondary to Treatment with Statins.
    Laakso M; Kuusisto J
    Curr Diab Rep; 2017 Feb; 17(2):10. PubMed ID: 28155189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The good and bad effects of statins on insulin sensitivity and secretion.
    Muscogiuri G; Sarno G; Gastaldelli A; Savastano S; Ascione A; Colao A; Orio F
    Endocr Res; 2014; 39(4):137-43. PubMed ID: 25208056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort.
    Cederberg H; Stančáková A; Yaluri N; Modi S; Kuusisto J; Laakso M
    Diabetologia; 2015 May; 58(5):1109-17. PubMed ID: 25754552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study.
    Puurunen J; Piltonen T; Puukka K; Ruokonen A; Savolainen MJ; Bloigu R; Morin-Papunen L; Tapanainen JS
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4798-807. PubMed ID: 24152688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study.
    Anyanwagu U; Mamza J; Donnelly R; Idris I
    Cardiovasc Diabetol; 2017 Aug; 16(1):107. PubMed ID: 28830436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic effects of metformin to rescue statin-induced muscle injury and insulin resistance: A proposed mechanism and potential clinical implications.
    Carris NW; Tipparaju SM; Magness DJ; Chapalamadugu KC; Magness RR
    Med Hypotheses; 2017 Sep; 107():39-44. PubMed ID: 28915960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetogenic Action of Statins: Mechanisms.
    Carmena R; Betteridge DJ
    Curr Atheroscler Rep; 2019 Apr; 21(6):23. PubMed ID: 31037345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of statin use with glycaemic traits and incident type 2 diabetes.
    Ahmadizar F; Ochoa-Rosales C; Glisic M; Franco OH; Muka T; Stricker BH
    Br J Clin Pharmacol; 2019 May; 85(5):993-1002. PubMed ID: 30838685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.
    van de Woestijne AP; van der Graaf Y; Westerink J; Nathoe HM; Visseren FL
    Am J Cardiol; 2015 Feb; 115(4):441-6. PubMed ID: 25554536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins Are Associated With Increased Insulin Resistance and Secretion.
    Abbasi F; Lamendola C; Harris CS; Harris V; Tsai MS; Tripathi P; Abbas F; Reaven GM; Reaven PD; Snyder MP; Kim SH; Knowles JW
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2786-2797. PubMed ID: 34433298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and diabetes risk: how real is it and what are the mechanisms?
    Robinson JG
    Curr Opin Lipidol; 2015 Jun; 26(3):228-35. PubMed ID: 25887679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use in Type 2 diabetes mellitus is associated with a delay in starting insulin.
    Yee A; Majumdar SR; Simpson SH; McAlister FA; Tsuyuki RT; Johnson JA
    Diabet Med; 2004 Sep; 21(9):962-7. PubMed ID: 15317599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG CoA reductase inhibitor treatment induces dysglycemia in renal allograft recipients.
    Choe EY; Wang HJ; Kwon O; Cho Y; Huh KH; Kim MS; Kim YS; Ahn CW; Cha BS; Lee HC; Kang ES
    Transplantation; 2014 Feb; 97(4):419-25. PubMed ID: 24285338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the role of adipsin in statin-induced glucose intolerance: a prospective open label study.
    Maini J; Rehan HS; Yadav M; Gupta LK
    Drug Metab Pers Ther; 2020 Apr; 35(1):. PubMed ID: 32229661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and their increased risk of inducing diabetes.
    Agouridis AP; Kostapanos MS; Elisaf MS
    Expert Opin Drug Saf; 2015; 14(12):1835-44. PubMed ID: 26437128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New onset diabetes mellitus induced by statins: current evidence.
    Chrysant SG
    Postgrad Med; 2017 May; 129(4):430-435. PubMed ID: 28276790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights.
    Galicia-Garcia U; Jebari S; Larrea-Sebal A; Uribe KB; Siddiqi H; Ostolaza H; Benito-Vicente A; Martín C
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of statins potentiates the insulin-sensitizing effect of exercise training in obese males with and without Type 2 diabetes.
    Meex RC; Phielix E; Schrauwen-Hinderling VB; Moonen-Kornips E; Schaart G; Schrauwen P; Hesselink MK
    Clin Sci (Lond); 2010 Jun; 119(7):293-301. PubMed ID: 20465545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.